You didn’t need to be in the room to access the insights
This presentation brings together the exclusive Beacon data presented at World Bispecific Summit 2026, giving bispecific developers a concise, visual overview of the forces shaping the field.
Explore where innovation is concentrating across modalities, mechanisms and targets, how programs are progressing through the clinic, and where commercial investment is flowing. The deck also looks ahead to notable assets and the developments that could influence the next phase of multispecific R&D.
For teams evaluating targets, benchmarking pipelines or monitoring competitors, it’s an opportunity to bring key conference intelligence back into your own decision-making.
What the slides cover:
- Where innovation is concentrating, including 2026 asset growth, clinical progression and approvals, plus changes across therapeutic classes and structural formats.
- The mechanisms and targets gaining momentum, with data on T cell engagers, NK and macrophage cell engagers, costimulation, target combinations, and disease indications attracting new development.
- How multispecific innovation is translating into the clinic, covering trial initiation and status changes, combination vs monotherapy development, completed studies and the drivers behind discontinuations.
- Commercial activity, including bispecific deal volume and value, notable transactions and the geographic distribution of active bispecific biopharma companies.
- The future direction of the field, highlighting assets to watch and emerging approaches including conditional activation in TCEs, costimulation and multispecific ADCs.
You May Also Be Interested In…
Learn More About Bispecific
- The Most Comprehensive Way to Search the Bispecific Drug Development Landscape: Unique search ontologies based on Bispecific drug and trial characteristics
- Market Leading Approach to Bispecific Preclinical & Clinical Data Curation: Manual curation of key Bispecific research and development data points Bispecific research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Bispecific company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
